Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Freeline Therapeutics Holdings plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $44.56M | $74.82M - $23.20M | N/A | $0.085 | 2 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | N/A | -$0.35 | 1 |
| Dec 2023 | $600.0K | $600.0K - $600.0K | N/A | -$0.52 | 2 |
| Dec 2022 | $617.0K | $1.04M - $321.3K | N/A | -$12.161 | 0 |